EDVA — Endovia Health Sciences Share News
0.000.00%
Last trade - 00:00- $1.63m
- $7.77m
- $0.07m
Brief: Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026
Brief: Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline
Brief: Splash Beverage Reports Second Quarter 2026 Results And Highlights Strategic Transformation Toward Endovia Health Sciences
Expands Cannepil License To Veterinary Therapeutics
Amends Settlement Agreements With Three Prior Investors On July 15, 2026 - SEC Filing
Brief: Argent Biopharma Enters Global Licensing Transaction
Brief: Splash Beverage Group Announces Leadership Transition And Strategic Evolution Toward High-Growth Wellness & Cannabinoid Markets
Brief: Splash Beverage Group Files For Non-Timely 10-K With US SEC
Brief: Splash Beverage Group Inc Executed Non-Binding Letter Of Intent For Proposed Merger With Medterra
Brief: Splash Beverage Group To Buy Exclusive Water Rights In Costa Rica
Brief: Splash Beverage Group Inc - Receives NYSE Notice Of Noncompliance - SEC Filing
Brief: NYSE American To Commence Delisting Proceedings Against Splash Beverage Group, Inc.
On March 20, Appointed William Devereux As CFO - SEC Filing
Brief: Splash Beverage Group Announces Julius Ivancsits Resigns As CFO
U.S. RESEARCH ROUNDUP-Applied Therapeutics, Brown-Forman, Ulta Beauty
Brief: Splash Beverage Group Inc - Procedural Notice Of Noncompliance Of NYSE Listing Standard
Brief: Splash Beverage Group Names Julius Ivancsits As Chief Financial Officer
Brief: Splash Beverage Acknowledges Going Concern Language in 10K
Brief: Splash Beverage Group Appoints John Paglia To Its Board Of Directors